(Q36712963)

15 August 2017

title

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. (English)

1 reference

15 August 2017

1 reference

1

Karel Pacak

1 reference

15 August 2017

4

Stefan R Bornstein

1 reference

15 August 2017

2

Graeme Eisenhofer

1 reference

15 August 2017

6

Ashley B Grossman

1 reference

15 August 2017

Håkan Ahlman

3

1 reference

15 August 2017

Anne-Paule Gimenez-Roqueplo

5

1 reference

15 August 2017

Noriko Kimura

7

1 reference

15 August 2017

Massimo Mannelli

8

1 reference

15 August 2017

Anne Marie McNicol

9

1 reference

15 August 2017

Arthur S Tischler

10

1 reference

15 August 2017

International Symposium on Pheochromocytoma

11

1 reference

15 August 2017

publication date

1 February 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

92-102

1 reference

Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma: Rediscovery as a catecholamine-metabolizing tumor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Detecting pheochromocytoma: defining the most sensitive test

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Clinical spectrum and outcome of functional extraadrenal paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytomas: detection with 11C hydroxyephedrine PET.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Germline SDHD mutation in familial phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Von Hippel-Lindau disease: a genetic study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma: the expanding genetic differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

1 reference

7 January 2021

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Characteristics of pheochromocytoma in a 4- to 20-year-old population

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma: state-of-the-art and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Perioperative management of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Phaeochromocytoma--recent progress in its management

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Tumor recurrence and hypertension persistence after successful pheochromocytoma operation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Laparoscopic adrenal surgery for recurrent tumours in patients with hereditary phaeochromocytoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Surgical management of hereditary pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Recommendations for the reporting of extra-adrenal paragangliomas. The Association of Directors of Anatomic and Surgical Pathology

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Recommendations for the reporting of tumors of the adrenal cortex and medulla. Association of Directors of Anatomic and Surgical Pathology

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Malignant pheochromocytoma: current status and initiatives for future progress

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Clinical experience over 48 years with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Pheochromocytomas: can malignant potential be predicted?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

"The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

High-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the analysis of catecholamines and metanephrines in human urine

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0396

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0396

1 reference

15 August 2017

1 reference